For over 75 years, Dana-Farber Cancer Institute has demonstrated an equal commitment to research and care that is unique among cancer centers.
- Dana-Farber is the only hospital ranked in the top five nationally by U.S. News & World Report in both adult and pediatric cancer care.
- Dana-Farber was named by Newsweek as the #4 best cancer hospital in the world, and was the only hospital in New England to be ranked in the top 13 for oncology.
- Dana-Farber is one of the largest recipients of grant funding from the National Cancer Institute.
- Dana-Farber investigators played a substantial role in developing more than half (51%) of all cancer drugs approved by the FDA in the last five years.
- Dana-Farber is a national leader in conducting clinical trials, and currently has more than 1,100 active clinical trials.
- Dana-Farber has one of the largest hematology/oncology training programs in the country, which has produced more leaders in oncology than any other program in the nation.
- Dana-Farber is a founding member of Dana-Farber/Harvard Cancer Center, one of 54 NCI-designated Comprehensive Cancer Centers in the U.S.
- Dana-Farber is a principal teaching affiliate of Harvard Medical School.
- Dana-Farber’s faculty are among the most highly cited researchers in the world. Thirty-three researchers were named to the “Highly Cited Researchers list” by the Institute for Scientific Information at Clarivate, demonstrating significant research influence among their peers.
- Dana-Farber and Laurie H. Glimcher, MD, president and CEO, were No. 1 on the Top 100 Women-Led Businesses in Massachusetts for the third consecutive year. The list iscompiled annually by The Women’s Edge and Globe Magazine to celebrate the state’s leading companies and nonprofits run by women.
- Dana-Farber faculty have been awarded two Nobel Prizes. William G. Kaelin Jr., MD, was the reciplient of the 2019 Nobel Prize in Physiology or Medicine, along with two other physician-scientists, for their discoveries of how cells sense and adapt to oxygen availability. Baruj Benacerraf, MD, was awarded the Nobel Prize in Physiology in 1980 for his breakthrough genetic findings.
Dana-Farber's achievements result from our relentless fight against cancer. Since the founding of our organization in 1947 by Dr. Sidney Farber, the father of modern chemotherapy, Dana-Farber is building momentum which will continue to change the landscape of cancer.
